| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/09/2005 | WO2005000403A3 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
| 06/09/2005 | WO2005000227A3 Methods of treating tnf-mediated disorders |
| 06/09/2005 | WO2004107618A9 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof |
| 06/09/2005 | WO2004105737A3 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents |
| 06/09/2005 | WO2004101602A3 Hepatitis c inhibitor peptide analogs |
| 06/09/2005 | WO2004098628A3 Synthetic peptide analogs of arg-pro-pro-gly-phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4 |
| 06/09/2005 | WO2004097405A3 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor h7tba62 (h7tba62) |
| 06/09/2005 | WO2004081021A3 Oligonucleotide mimetics |
| 06/09/2005 | WO2004080421A3 Improved antitumoral treatments |
| 06/09/2005 | WO2004043383A8 A new target for angiogenesis and anti-angiogenesis therapy |
| 06/09/2005 | WO2004041118A8 Therapeutic compositions for drug delivery to and through covering epithelia |
| 06/09/2005 | WO2004040298A3 Tumor marker proteins for diagnosis and therapy of cancer and cancer risk assessment |
| 06/09/2005 | WO2004039999A3 Essential dna enclosed proteins of drosphophilia melanogaster |
| 06/09/2005 | WO2002048312A3 Backbone cyclized inhibitors of heat shock proteins |
| 06/09/2005 | US20050125851 Methods of diagnosis and treatment of interstitial lung disease |
| 06/09/2005 | US20050125846 Expression vector comprising nucleotide sequences coding transmembrant transport protein for use in diagnosis, treatment and prevention of thyroid disorders |
| 06/09/2005 | US20050125039 Treatment of hepatitis C using hyperthermia |
| 06/09/2005 | US20050124979 Miniaturized device; substrate with reservoirs; aperture; barrier covering; sustained release |
| 06/09/2005 | US20050124862 Thyroid hormone analogs and methods of use |
| 06/09/2005 | US20050124802 Novel human membrane proteins and polynucleotides encoding the same |
| 06/09/2005 | US20050124801 Nucleotide sequences coding cell growth factor polypeptides fusions for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 06/09/2005 | US20050124796 Mouse cytokine receptor |
| 06/09/2005 | US20050124795 DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor |
| 06/09/2005 | US20050124794 Histidine-proline rich tropomyosin-related anti-angiogenic receptor polypeptide or peptide tor use in prevention and treatment of tumor |
| 06/09/2005 | US20050124789 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/09/2005 | US20050124787 Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 06/09/2005 | US20050124645 Methods and compositions for increasing CD4lymphocyte immune responsiveness |
| 06/09/2005 | US20050124605 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating circulatory, inflammatory, and proliferative disorders |
| 06/09/2005 | US20050124597 Novel guanidinyl derivatives |
| 06/09/2005 | US20050124573 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 06/09/2005 | US20050124569 chemically synthesized double stranded siNA against Chemokine CXC Motif, Receptor 4 (CXCR4); modulate chemokine receptors such as CXCR4 and CXCR7A; use to inhibit viral infection (e.g., HIV), inflammatory diseases |
| 06/09/2005 | US20050124568 Moderating gene expression; mixture of small nucleic acids |
| 06/09/2005 | US20050124567 Apoptosis; controlling central nervous system disorders |
| 06/09/2005 | US20050124566 Using small nucleic acid as moderators of gene expression |
| 06/09/2005 | US20050124553 Erectile dysfunction |
| 06/09/2005 | US20050124552 Use of glutathione synthesis stimulating compounds in reducing insulin resistance |
| 06/09/2005 | US20050124551 Or its cystine-coupled dimer, mixed with a nonsteroidal antiinflammatory agent used to treat contact dermatitis. |
| 06/09/2005 | US20050124550 Compounds that modulate the glucagon response and uses thereof |
| 06/09/2005 | US20050124549 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 06/09/2005 | US20050124547 Tau-conotoxin peptides |
| 06/09/2005 | US20050124546 Oligopeptide lyophilisate, their preparation and use |
| 06/09/2005 | US20050124545 Cosmetic or parmaceutical composition containing peptides |
| 06/09/2005 | US20050124544 Peptide decoys for the preparation of medicaments intended for the prevention or treatment of autoimmune pathologies or disorders linked to the appearance of antibodies directed against exogenous proteins |
| 06/09/2005 | US20050124543 Heterologous polypeptide of the TNF family |
| 06/09/2005 | US20050124542 Using aqueous solution of glucangon-like peptide and solvent; crystallization; isolation of crystals |
| 06/09/2005 | US20050124541 Improving heart function by increasing venturicular contaction using growth hormone |
| 06/09/2005 | US20050124539 Ligand which binds to polypeptides; controlling eating disorders; screening process |
| 06/09/2005 | US20050124538 for prophylaxis, prevention, treatment or therapy of inflammatory conditions or allergic reactions in a mammal; binds bacterial lipopeptide |
| 06/09/2005 | US20050124537 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/09/2005 | US20050124536 Antifungal combination use |
| 06/09/2005 | US20050124534 In a tissue, organ or wound site using a synergistic mixture of transforming growth factor beta inhibitors and agents that degrade the excess accumulated extracellular matrix; fibrotic diseases and scarring |
| 06/09/2005 | US20050124533 Central nervous system disorders; adjust permeability of brain-bnlood barrier |
| 06/09/2005 | US20050124531 Angiogenesis inhibitors; prevent cancer cells metastasis; antiarthritic agents; skin disorders; retinopathy; atherosclerosis |
| 06/09/2005 | US20050124071 Methods and compositions for diagnosing musculoskeletal, arthritic and joint disorders by biomarker dating |
| 06/09/2005 | US20050124064 Antimicrobial polypeptides from pseudoplectania nigrella |
| 06/09/2005 | US20050124056 For diagnosing rheumatoid arthritis |
| 06/09/2005 | US20050124054 Novel proteins and methods for producing the proteins |
| 06/09/2005 | US20050124045 Comprising a peptide linker, and a human IgG Fc variant with amino acid mutations; encoded by DNA from a transfected cell line; culture purification; improved pharmacokinetics, extended serum half-life, side effects reduction; treating chronic anemia due to renal diseases |
| 06/09/2005 | US20050124043 Chemotactic cytokine for use in diagnosis, prevention and treatment of tumors |
| 06/09/2005 | US20050124042 Method for expression of heterologous proteins in yeast |
| 06/09/2005 | US20050124039 Mixing cationic lipid with a polynucleotide, coding for antigenic determinant, thereby forming a cationic lipid-polynucleotide complex; administering complex to animal for eliciting an immune response |
| 06/09/2005 | US20050124036 Method for producing recombinant proteins in micro-organisms |
| 06/09/2005 | US20050124034 Preparing preferential peptide from fish skin via salt water cleansing, proteolytic digestion, activated carbon concentration and drying; for use in food and medicine supplements |
| 06/09/2005 | US20050124004 Histamine receptor h3 polynucleotides |
| 06/09/2005 | US20050123999 Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods |
| 06/09/2005 | US20050123982 Solute carrier transport protein peptide for use in treatment and prevention of nervous system and cell proliferative disorders |
| 06/09/2005 | US20050123977 Using variation in tumor suppressor protein gene (p53) as diagnostic tool in detection and treatment of cell proliferative disorders |
| 06/09/2005 | US20050123967 Using high in normal-1(HIN-1) gene expression as diagnostic tool in detection of cell proliferative disorders |
| 06/09/2005 | US20050123960 Secretory glaucoma protein (myocilin) for use as diagnostic and therapeutic tool in identifying modulators of vision loss |
| 06/09/2005 | US20050123949 Transmembrane proteins for use in identifying modulator for treatment of inflammatory, splenic, bone, respiratory and cell proliferative disorders |
| 06/09/2005 | US20050123942 Nucleotide sequences coding kinase for use as tool in diagnosis, prevention and treatment of restenosis, cell proliferative and ischemic disorders |
| 06/09/2005 | US20050123925 Compositions and methods for the diagnosis and treatment of tumor |
| 06/09/2005 | US20050123920 Jade nucleic acids, proteins and uses thereof |
| 06/09/2005 | US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders |
| 06/09/2005 | US20050123910 Nucleotide sequences coding prolyl oligopeptidase (DPP10) for use in identifying modulator which prevent and treat allergies, asthma, skin and inflammatory diseases |
| 06/09/2005 | US20050123905 Relicating preferential nucleotide sequences using mixture comprising polymerase-amplified nucleic acid having a 5' overhang, a vector having a 3' overhang and an antibody that binds polymerase; improving exogenous gene expression |
| 06/09/2005 | US20050123904 Using viral kinase as tool to identify modulators of gammaherpesviral replication; enzyme inhibitors and gene expression inhibition; viricides |
| 06/09/2005 | US20050123902 Human papillomavirus inhibitors |
| 06/09/2005 | US20050123899 Viricidal agent comprising mannose binding protein for use in directed destruction of viral particles associated with human immunodeficiency syndrome |
| 06/09/2005 | US20050123634 Method for modulating steroidogenic activity |
| 06/09/2005 | US20050123628 Compositions and methods useful for treating and preventing chronic liver disease, chronic HCV infection and non-alcoholic steatohepatitis |
| 06/09/2005 | US20050123618 Method of producing micro-capsules for the sustained release of drugs |
| 06/09/2005 | US20050123617 Biodegradable polymeric nanocapsules and uses thereof |
| 06/09/2005 | US20050123610 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof |
| 06/09/2005 | US20050123605 Anticancer agents; prevent forming blood vessels; removal blockage |
| 06/09/2005 | US20050123603 Oral delivery vehicle; food products |
| 06/09/2005 | US20050123597 Releasable linkage and compositions containing same |
| 06/09/2005 | US20050123594 contacting a liposome ( lectin, glycolipid, phospolipid) with RLIP76 protein to create a proteoliposome; detoxifies xenobiotics by a process that catalyzes ATP; protection against toxic by-products of metabolism, stress, and drugs |
| 06/09/2005 | US20050123592 Pharmaceutical compositions and methods for insulin treatment |
| 06/09/2005 | US20050123583 Biocompatible implant; crosslinking an amine-containing biological material such as chitosan, collagen, elastin, gelatin, fibrin glue, with beta -hydroxypropinoaldehyde |
| 06/09/2005 | US20050123579 System for treating heart disease and cardiovascular disease in diabetic and non-diabetic patients |
| 06/09/2005 | US20050123569 Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor |
| 06/09/2005 | US20050123568 Chromatographic purification steps using unbuffered aqueous bases as eluent and subsequent neutralization; low side effect for specific immunotherapy of this pollen allergy; reduced immunoglobulin E binding with simultaneous retention of therapeutically relevant T-cell stimulation |
| 06/09/2005 | US20050123567 Botulinum toxin therapy for skin disorders |
| 06/09/2005 | US20050123558 Modifeid polypeptide |
| 06/09/2005 | US20050123557 AntiI-protozoal vaccine |
| 06/09/2005 | US20050123552 Anti-(fibronectin binding site) antibodies, peptides and epitopes that give rise to antibodies that block the binding of fibronectin binding proteins to fibronectin |
| 06/09/2005 | US20050123551 Nucleic acids encoding polypeptides present in normal and neoplastic endometrial cells for use in diagnosis and treatment of endometrial cancer, identifying endometrial tissue; vectors, host cells; vaccines against endometrial cancer |
| 06/09/2005 | US20050123548 Modified peptides as therapeutic agents |
| 06/09/2005 | US20050123543 With an integrin linked kinase (ILK) inhibitor which can be a peptide, an antibody, an antisense agent; optionally also treating with an ACE inhibitor; ACE (Angiotensin Converting Enzyme) |